MedTrace Logo

Systemic Screening for Hereditary Colorectal Cancer in China

NCT03365986 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2017-12-12

No results posted yet for this study

Summary

The purpose of the this study is to determine the prevalence of germline cancer susceptibility gene mutation among Chinese population, and to find best ways to screen patients with colorectal cancer in China. To accomplish this objective, the investigators will establish a large sample database of hereditary colorectal cancer related information using multigene panel testing based on Next-Generation Sequencing.

Conditions

  • Hereditary Colorectal Cancer

Interventions

DIAGNOSTIC_TEST

genetic screening

Patients receive genetic test to see whether they have germline cancer susceptibility gene mutations

Sponsors & Collaborators

  • Sun Yat-sen University

    lead OTHER

Principal Investigators

  • Ding Peirong, MD · Sun Yat-sen University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-01
Primary Completion
2018-03-31
Completion
2018-03-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03365986 on ClinicalTrials.gov